04/09/2020
8:42 AM | Artisan Partners Limited Partnership (Filed by)
Halozyme Therapeutics (Subject)
| Form SC 13G
| |
04/03/2020
7:03 AM | Halozyme Therapeutics (Filer)
| Form DEFA14A
| |
03/19/2020
6:28 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
7:04 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
7:03 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
7:02 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
3:16 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
3:15 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
5:41 PM | Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
5:39 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
5:38 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
5:24 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
5:05 PM | Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
5:03 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
4:59 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
4:56 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2020
1:24 PM | Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/10/2020
12:41 PM | Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/04/2020
3:11 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/28/2020
8:56 AM | Halozyme Therapeutics (Subject)
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by)
| Form SC 13G/A
| |
01/16/2020
3:25 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2020
3:23 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2019
4:02 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2019
5:06 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
3:15 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2019
3:53 PM | Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
| Form SC 13D/A
| |
11/05/2019
3:36 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2019
6:10 PM | Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
10:20 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
3:18 PM | Halozyme Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2019
7:11 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
3:01 PM | Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
| Form SC 13D/A
| |
06/17/2019
7:19 AM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
12:40 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2019
4:10 PM | Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
| Form SC 13D/A
| |
06/03/2019
4:22 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2019
4:10 PM | Halozyme Therapeutics (Filer)
| Form S-8 POS
| |
05/07/2019
3:08 PM | Halozyme Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2019
3:01 PM | Armour Alison A. (Reporting)
Halozyme Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/03/2019
4:05 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2019
3:23 PM | Halozyme Therapeutics (Issuer)
Posard Matthew L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2019
3:20 PM | Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2019
3:12 PM | Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2019
3:10 PM | Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2019
3:08 PM | Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2019
3:07 PM | Halozyme Therapeutics (Filer)
| Form DEF 14A
| |
02/22/2019
6:04 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
6:03 PM | Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
6:03 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
6:02 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2019
3:16 PM | Halozyme Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2019
3:04 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2019
7:10 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4/A
| |
02/15/2019
4:36 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
4:34 PM | Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
4:33 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
4:32 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
5:29 PM | Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
5:28 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
5:26 PM | Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
5:24 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
5:22 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
2:48 PM | BB BIOTECH AG (Filed by)
Halozyme Therapeutics (Subject)
| Form SC 13G/A
| |
02/11/2019
1:00 PM | Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/06/2019
5:02 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2019
1:21 PM | Halozyme Therapeutics (Subject)
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by)
| Form SC 13G/A
| |
02/05/2019
3:12 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2019
3:11 PM | Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2019
3:10 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2019
4:04 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2018
3:26 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2018
3:19 PM | Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2018
4:00 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2018
3:14 PM | Halozyme Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2018
3:08 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2018
3:10 PM | Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2018
3:17 PM | Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2018
5:24 PM | Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2018
5:21 PM | Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/10/2018
8:01 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2018
5:06 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2018
4:25 PM | Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2018
4:23 PM | Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
| Form SC 13D/A
| |
08/23/2018
3:33 PM | Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2018
4:19 PM | Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
| Form SC 13D/A
| |
08/16/2018
4:16 PM | Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2018
4:00 PM | Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2018
3:29 PM | Halozyme Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2018
3:24 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2018
5:58 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2018
3:35 PM | Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2018
8:55 PM | Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
3:23 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2018
3:06 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2018
4:19 PM | Halozyme Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2018
3:37 PM | Halozyme Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2018
4:09 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2018
6:42 PM | Halozyme Therapeutics (Issuer)
Posard Matthew L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2018
6:42 PM | Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2018
6:41 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
